Posted on 07/12/2009 in Pharmaceutical Company Financials UCB has finalised the placement of 500 million euros (451 million pounds) worth of senior unsecured bonds that were due in 2016, it has revealed.
The transaction, which was placed through an accelerated book-building placement with European investors, was conducted by financial institutions such as ABN AMRO Bank NV, Calyon, Commerzbank, ING Bank and Mizuho Corporate Bank, acting as lead managers for the offering.
Meanwhile, Santander and BNP Paribas Fortis will act as co-managers for the offering.
"The success of our latest offering underlines UCB's access to the debt capital markets and allows us to further diversify our international lender base and extend our debt maturity profile," stated Detlef Thielgen, chief financial officer of UCB.
Last month, the company announced that it would alter the operations carried out at its site in Slough, as well as at its Belgian base in Braine-l'Alleud.
This, it explained, is to better position itself for a strong future. Other news stories from 07/12/2009
Read more in the Zenopa News Archive
How this news is generated
|
